Image

Comparing The Safety And Efficacy Of DEFENCATH® In Reducing Central-Line Bloodstream Infections (CLABSIs) In Adults Receiving Total Parenteral Nutrition Through A Central Venous Catheter (CVC)

Studying DEFENCATH® to reduce infections in adults with central line nutrition.

Recruiting
18 years and older
All
Phase 3

Study Overview: This study is looking at how well a medicine called DEFENCATH® works to stop infections in people who need a special kind of nutrition called Total Parenteral Nutrition (TPN). TPN is given through a tube called a Central Venous Catheter (CVC) because some people can't eat food the normal way. The study will compare DEFENCATH® to another medicine called heparin.

Key Points:

  • Participants need to visit multiple times and be able to follow study rules, like keeping a diary and using medicines correctly.
  • Participants must be on TPN for at least 3 days a week, and the study will last over 6 months.
  • Participants should not have certain health issues like skin infections at the catheter site or be taking certain medications.

Eligibility: Participants must be 18 years or older, living in the US or Türkiye, and need TPN for more than 6 months. They should not have had antibiotics recently or other medical conditions listed in the exclusion criteria, like unstable heart conditions or recent bone marrow transplants.

Study details
    Central Line Associated Blood Stream Infections (CLABSI)

NCT06822426

CorMedix

7 March 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Race
Ethnicity
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.